Thaemert v. Honeywell Int'l, Inc., 122018 MNWC, WC18-6164

Case DateDecember 20, 2018
CourtMinnesota
BARBARA J. THAEMERT, Employee/Appellant,
v.
HONEYWELL INT'L, INC., SELF-INSURED, and SEDGWICK CLAIMS MGMT. SERVS., INC., Employer-Insurer/Respondents
and
INJURED WORKERS' PHARMACY, Intervenor.
No. WC18-6164
Minnesota Workers Compensation
Workers' Compensation Court of Appeals
December 20, 2018
         MEDICAL TREATMENT & EXPENSE - REASONABLE & NECESSARY. Substantial evidence in the record does not support the compensation judge's denial of claimed medical treatment according to whether the claimed medical treatment was reasonable and necessary.          EVIDENCE - EXPERT MEDICAL OPINION. Where the report prepared by the independent medical examiner relied on assumptions which are contradictory to the facts as found by the compensation judge and was otherwise unsupported by evidence in the record, reliance on the opinion of the independent medical examiner is error.           Charles M. Cochrane, Cochrane Law Office, Roseville, Minnesota, for the Appellant.           Jeffrey G. Carlson, Brown & Carlson, P.A., St. Louis Park, Minnesota, for the Respondents.           Determined by: Patricia J. Milun, Chief Judge, David A. Stofferahn, Judge, Gary M. Hall, Judge, Deborah K. Sundquist, Judge, Sean M. Quinn, Judge           Compensation Judge: James F. Cannon          Disposition: Vacated in part and remanded.           OPINION           PATRICIA J. MILUN, Chief Judge.          The employee appeals from the compensation judge's determination, relying on the opinion of the self-insured employer's independent medical examiner, that the employee's current medical claim for narcotic medications does not constitute medical treatment that was reasonable, necessary, and causally related to the work-related injuries on January 29, 1993, and June 17, 1998. We vacate Findings 17 and 19-23 and the denial of benefits, and remand to the compensation judge for reconsideration.          BACKGROUND          The employee, Barbara Thaemert, worked at Honeywell, the self-insured employer, from 1977 until June 1998. The employee suffered an admitted work injury on January 29, 1993, as a result of assembly work, largely consisting of connecting parts and pinching wires. She began experiencing headaches and pain in her neck, bilateral shoulders, and bilateral arms. First seeking chiropractic treatment, physical therapy, and massage therapy, she then began treating with A.V. Anderson, M.D., in May 1993. Dr. Anderson diagnosed the employee with degenerative disc and joint disease in the cervical spine at C3 through C6, tendinitis of the right shoulder, and lateral epicondylitis of the upper right arm. In 1995, Dr. Anderson concluded the employee was at maximum medical improvement (MMI) for the January 29, 1993, work injury; opined continuing conservative care was appropriate to address the effects of that injury; and rated the employee with a permanent partial disability (PPD) of 10.5 percent for the cervical spine and 3 percent for the right shoulder.          In December 1995, Dr. Anderson prescribed Tylenol #3, an opioid medication, to be taken as needed for pain. The employee had been taken off work for one week due to an aggravation of her pain symptoms. Dr. Anderson noted the employee had a 50 percent reduction of her pain due to the use of Tylenol #3. In June 1996, Dr. Anderson noted that the employee needed Tylenol #3 for sufficient pain relief to be able to sleep. In March 1997, Dr. Anderson noted the employee was unable to continue working without the pain relief provided by Tylenol #3, and the employee's use of that medication was reduced when she was not working. On January 21, 1998, Dr. Anderson began the employee on a trial of oxycodone as a replacement for the Tylenol #3 pain medication. The employee credited her ability to work full time to the pain relief she was receiving from the medication.          The employee suffered an alleged work injury on June 17, 1998, which caused her to be taken off work by Dr. Anderson. The claimed work injury was bilateral carpal tunnel syndrome, which the employee attributed to her work duties. An EMG study supported the diagnosis. The employee did not resume working for the employer.          At a follow-up appointment on July 15, 1998, Dr. Anderson noted the employee's use of OxyContin (20 mg) to address her ongoing pain symptoms and Oxycodone for breakthrough pain. After the failure of conservative treatment, the employee underwent carpal tunnel surgery on the right side in December 1998, and on the left side in February 1999. Both surgeries were performed by David R. Olson, M.D. On May 5, 1999, Dr. Anderson noted the employee's continued use of OxyContin and Oxycodone, and indicated the employee was experiencing ongoing pain symptoms resulting in other adverse effects, such as sleep interruption. On June 16, 1999, Dr. Anderson documented the employee's physical symptoms, including muscle spasms, which he considered consistent with the employee's complaints of pain.          On December 15, 1998, the employee underwent an independent medical examination (IME) by Joseph T. Teynor, M.D., on behalf of the self-insured employer. Dr. Teynor opined the employee did not suffer a Gillette[1] injury at work. Dr. Teynor considered the employee's ongoing use of narcotic medications to be unnecessary to treat any claimed work injury with the employer.          On December 17, 1999, Dr. Anderson provided a narrative letter describing the employee's condition, including the unsuccessful effort to address arm pain through carpal tunnel surgery. Dr. Anderson attributed the employee's ongoing pain syndrome to her 22 years of assembly work. Dr. Anderson increased the employee's PPD rating, and considered the employee to be permanently and totally disabled. Dr. Anderson noted the ongoing opioid prescriptions were needed to give the employee enough pain relief to sleep and perform ordinary activities of daily living (hereinafter ADLs).          On March 2, 2000, Dr. Anderson conducted a follow-up examination and again opined the employee was permanently and totally disabled. Dr. Anderson also noted the employee's medications substantially reduced her pain and improved her overall functioning.          On May 12, 2000, the employee underwent a second JJVIE by Dr. Teynor, on behalf of the self-insured employer. Dr. Teynor opined the employee's ongoing symptoms did not arise from any work injury with the employer.          On July 12, 2000, Dr. Anderson conducted a follow-up examination and noted the employee's ongoing prescription for opioids was consistent with current medical practice and was needed to provide sufficient functioning for ADLs.          On April 4, 2001, Dr. Olson provided a narrative report regarding the employee's carpal tunnel condition. Dr. Olson discussed permanent restrictions and a permanent partial disability rating which would be either zero percent or three percent, depending on the outcome of a subsequent EMG arising from that condition and the relative success of the surgery. There was no discussion of chronic pain and no discussion of the employee's opioid treatment.          The parties reached a settlement and on July 19, 2001, an Award on Stipulation was filed. The employee received $70,000, less attorney fees of $14,200, for a close-out of claims including...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT